BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kalpatthi R, Kiss JE. Thrombotic Thrombocytopenic Purpura, Heparin-Induced Thrombocytopenia, and Disseminated Intravascular Coagulation. Crit Care Clin 2020;36:357-77. [PMID: 32172818 DOI: 10.1016/j.ccc.2019.12.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Moreno G, Carbonell R, Bodí M, Rodríguez A. [Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients]. Med Intensiva (Engl Ed) 2021;45:42-55. [PMID: 32646669 DOI: 10.1016/j.medin.2020.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Trancǎ SD, Antal O, Farcaş AD. Case Report: Acute Splenic Artery Thrombosis in a COVID 19, Postpartum Patient. Front Med (Lausanne) 2021;8:698627. [PMID: 34805195 DOI: 10.3389/fmed.2021.698627] [Reference Citation Analysis]
3 Zamora DI, Gonzalez LM. Hypertensive Emergency as the Initial Presentation of Acquired Thrombotic Thrombocytopenic Purpura: A Case Report. Cureus 2021;13:e20176. [PMID: 34877232 DOI: 10.7759/cureus.20176] [Reference Citation Analysis]
4 Avila J, Long B, Holladay D, Gottlieb M. Thrombotic complications of COVID-19. Am J Emerg Med 2021;39:213-8. [PMID: 33036855 DOI: 10.1016/j.ajem.2020.09.065] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
5 Karabulut K, Andronikashvili A, Kapici AH. Recurrence of Thrombotic Thrombocytopenic Purpura after mRNA-1273 COVID-19 Vaccine Administered Shortly after COVID-19. Case Rep Hematol 2021;2021:4130138. [PMID: 34552799 DOI: 10.1155/2021/4130138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]